Targeting oxidative stress in disease: promise and limitations of antioxidant therapy

Area of Science:

• Biochemistry and Molecular Biology
• Pathophysiology
• Pharmacology

Background:

• Oxidative stress is implicated in numerous diseases, including atherosclerosis, COPD, Alzheimer disease, and cancer.
• Preclinical studies show promise for antioxidant therapies, but clinical trials have yielded disappointing results.
• A deeper understanding of antioxidant mechanisms is needed for successful pharmacological interventions.

Purpose of the Study:

• To review the complex relationships between oxidative stress, redox signaling, and disease pathology.
• To elucidate the mechanisms by which oxidative stress contributes to disease.
• To explore the limitations of current antioxidant defenses and strategies for enhancement.

Main Methods:

• Literature review of studies on oxidative stress, redox signaling, and antioxidant mechanisms.
• Analysis of preclinical and clinical trial data on antioxidant therapies.
• Synthesis of information on physiological, dietary, and pharmaceutical approaches to modulate antioxidant defenses.

Main Results:

• Oxidative stress plays a significant role in the pathogenesis of various chronic diseases.
• The effectiveness of antioxidant interventions is often limited by complex biological mechanisms and delivery challenges.
• Enhancing endogenous antioxidant defenses through physiological or pharmaceutical means may offer a more promising therapeutic strategy.

Conclusions:

• Targeted understanding of antioxidant action is crucial for overcoming the limitations of current therapeutic approaches.
• Future strategies should focus on enhancing endogenous antioxidant capacity and optimizing intervention timing and targets.
• Further research into redox signaling pathways is essential for developing effective treatments for oxidative stress-related diseases.